Health Care & Life Sciences

Cancer drug developer Endocyte files for IPO

August 18, 2010
Scott Olson
The company, headquartered at Purdue Research Park, said the number of shares to be offered and their price range have yet to be determined.
More

Lilly Alzheimer's drug prospect only the latest to fail

August 18, 2010
Bloomberg News
A dozen potential products designed to slow or stop clumps of protein from forming in the brain, a condition linked to the disease since 1906, have failed in mid- to late-stage testing since 2003.
More

Expanding hospitals target Bloomington

August 18, 2010
J.K. Wall
Monroe Hospital in Bloomington is the latest target in the statewide buildup by hospital systems. St. Vincent Health, St. Francis and at least one other system have all had talks in the past month with Monroe.
More

Q&A

August 18, 2010
J.K. Wall
Dr. Kevin Macadaeg, vice president of the Indiana Spine Group, talked about his physician group's decision to build a 60,000-square-foot medical office and "bioskills" lab in Carmel next year, as well as the group's commitment to grow independently in the face of pressures from hospital acquisitions and health reform.
More

Bad news piles up for Lilly

August 18, 2010
J.K. Wall
What a tough week for Lilly. On Aug. 12, a judge struck down the Indianapolis-based drugmaker’s U.S. patent on Strattera, which might cost the company about $450 million in annual revenue. Then, five days later, Lilly halted clinical trials on one of its experimental Alzheimer’s medicines, because patients did worse on the drug than on a placebo.
More

Lilly's Cymbalta helps chronic pain in U.S. review

August 17, 2010
Bloomberg News
Approval for the millions of Americans with chronic back or knee pain may add more than $500 million, or 16 percent, to Cymbalta's annual sales.
More

Lilly halts development of Alzheimer's drug

August 17, 2010
 IBJ Staff and Associated Press
Studies showed that the treatment did not slow the disease's progression. It's just the latest setback for the pharmaceutical giant, which lost a patent lawsuit over a major drug last week and faces an unprecedented number of patent expirations through 2014.
More

Medco to acquire United BioSource for $710M

August 16, 2010
 IBJ Staff and Bloomberg News
Medco operates an automated pharmacy and distribution center in Whitestown in Boone County, and it plans to employ more than 1,400 people there by 2012.
More

Lilly braces for plunge in profits

August 14, 2010
J.K. Wall
Indianapolis-based drugmaker Eli Lilly and Co. faces such an unprecedented string of patent expirations and an unheard-of loss of revenue that it's hard to picture what the company will look like in five years.
More

WellPoint, other health insurers race to join accountable care groupsRestricted Content

August 14, 2010
J.K. Wall
The health care industry is responding to reforms that will pay doctors bonuses if they provide high-quality care and save Medicare money.
More

Bedsore preventer turns to detectionRestricted Content

August 14, 2010
Chris O'Malley
Changes in reimbursement could fuel market for WoundVision's product.
More

Indiana life sciences group moves aheadRestricted Content

August 14, 2010
Scott Olson
INpact not-for-profit arranged virtual approach to help startup firm develop device to detect tooth cavities early.
More

Life sciences panel pegs bright spots in IndianaRestricted Content

August 14, 2010
Leaders tackle issues ranging from research to cold storage to the future of Eli Lilly and Co.
More

Biomet investing $26M to expand, create nearly 280 jobs

August 13, 2010
 IBJ Staff
Orthopedics giant Biomet Inc. plans to invest $26 million to grow operations in its hometown of Warsaw, adding 278 jobs by the end of 2012.
More

Eli Lilly loses patent lawsuit for Strattera

August 13, 2010
 IBJ Staff and Associated Press
Eli Lilly and Co. on Thursday lowered its revenue outlook for the year after it lost a patent lawsuit over its attention deficit hyperactivity drug Strattera. The patent had been set to expire in May 2017. Lilly plans to appeal.
More

Roche hit with new breed of patent suit

August 11, 2010
J.K. Wall
Roche Diagnostics, a Swiss company that keeps its U.S. headquarters in Indianapolis, has been sued for marking its Accu-Chek blood glucose monitors and accessories with patents that are expired. Illinois resident David O’Neill has sued on behalf of the U.S. government to recover damages of $500 per infraction.
More

Court defeat lost in Lilly's gloomy long-term outlook

August 9, 2010
J.K. Wall
Eli Lilly and Co.'s loss of a patent on one of its blockbuster drugs in court late last month received a collective yawn from investors, who have shunned the stock because of five looming patent expirations.
More

Arcadia sees smaller loss, extends WellPoint pact

August 9, 2010
 IBJ Staff
Indianapolis-based health care firm reaches agreement to offer its DailyMed product to more WellPoint Inc. health plan members.
More

Indiana universities offer cash incentives for technology transfer

August 7, 2010
 IBJ Staff
The Indiana Clinical and Translational Sciences Institute awarded $750,000 to 10 teams of researchers.
More

Former commerce chief lands at local company

August 4, 2010
Scott Olson
Nate Feltman, former state secretary of commerce, has left his partnership position at Baker & Daniels LLP to become president of Home Health Depot LLP, a growing home-medical-equipment supplier.
More

Analyst: Arcadia sales poised to take off

August 4, 2010
J.K. Wall
Arcadia Resources’ DailyMed business will grow revenue 10-fold in the next three years and push the Indianapolis-based company into profitability, according to a research report by the first analyst to officially cover the company.
More

CNO Financial profits surge 20 percent, beating expectations

August 3, 2010
J.K. Wall
The Carmel-based life and health insurer earned $33.1 million in the three months ended June 30, or 12 cents per diluted share. Excluding losses on investments and retired debt, the company would have earned 16 cents per share.
More

Wellness-based development would be first of kind here

August 3, 2010
Tom Harton
Satori Pointe is being marketed as a campus where medical offices, fitness-oriented retailers and residents would co-exist.
More

Dow Agro boosts sales, profit in second quarter

August 3, 2010
 IBJ Staff and Bloomberg News
Indianapolis-based Dow AgroSciences improved sales and profit in its second quarter thanks to higher volumes and lower costs, the company said Tuesday morning.
More

WellPoint, peers focus on health reform rules, campaign

August 3, 2010
Bloomberg News
WellPoint Inc., UnitedHealth Group Inc. and three other health insurers, criticized by Democrats during the health care reform debate, are seeking to influence how the new law will be implemented, and possibly change it, by campaigning for supportive congressional candidates.
More
Page  << 61 62 63 64 65 66 67 68 69 70 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. The Walgreens did not get a lot of traffic. It was not located on the corner of the intersection, and not really visible from Emerson. Meanwhile the CVS there is huge and right on the corner. I am guessing a lot of people drove by a million times and never knew the Walgreens was there. Although, with the new Walmart market going in, that area could really see a lot of increase in traffic soon.

  2. You folks don't have a clue. There is a legal way to enter this country and to get aid. This left unchecked could run us to ruin quickly. I also heard that 'supporters' were getting major $$ to take them in? Who's monitoring this and guess who pays the bill? I support charitable organizations... but this is NOT the way to do it!

  3. Apparently at some time before alcohol has been served at the fair. The problem is that beer or wine used to be a common drink for people before soft drinks and was not thought to be that unusual. Since many folks now only drink to see how much they can drink or what kind of condition they can end up in it becomes more problematic. Go to Europe and its no big deal just as if you had sodas of milk to drink everyday. Its using common sense that is lacking now days.

  4. To address the epic failure of attracting race fans to both the Indy 500 and Brickyard 400 would take too much of my time to write. Bottom line Boles is clueless and obviously totally out of touch with the real paying fan base. I see nothing but death spin coming for the Brickyard, just like Indy. Get somebody in a place of power that understands what race fans want.

  5. I am a race fan through & through. It doesn't matter if it's Indy cars or Nascar. I love a great race. I go to several other tracks each year and you can see the entire track. I know Indy has tradition, but fans want to see the entire race. I sit in the Penthouse, am almost 60 years old, and would like to see a better TV screen in turn 1 so you can see the entire race. Then I think Indy needs to install an escalator so us old folks can make it up to the Penthouse and down again if we want more options to purchase food and drinks. Just a race fans opinion. Lights won't make the race any better, but you might be able to see the TV better at night. Turn 1's screen needs replaced with a better and bigger screen.

ADVERTISEMENT